Trintellix (vortioxetine) withdrawal symptoms typically last about 7 days, though the range spans roughly 3 to 10 days for most people. Symptoms tend to appear around 3 days after stopping the medication, not immediately, because the drug leaves your body slowly.
When Symptoms Start and How Long They Last
A retrospective chart review published in the National Library of Medicine found that withdrawal symptoms emerged a median of 3 days after stopping vortioxetine. That delay makes sense given the drug’s pharmacology: Trintellix has an unusually long half-life of roughly 50 to 70 hours after a single dose, meaning it takes days for blood levels to drop low enough to trigger withdrawal effects.
Once symptoms appeared, they resolved on their own within 3 to 10 days, with a median of 7 days. So from the day you take your last pill, the typical arc looks something like this: a few days of feeling normal, followed by about a week of withdrawal symptoms that gradually fade. Most people are through the worst of it within two weeks of their last dose.
Why Trintellix Leaves Your System Slowly
Trintellix is absorbed and eliminated more slowly than many other antidepressants. After a single dose, the drug takes a median of 12 hours just to reach peak levels in your blood. Elimination is equally gradual, with a half-life that ranges from about 50 hours up to 113 hours depending on the person, the dose, and how long they’ve been taking it. In older adults, the half-life can stretch even longer, averaging around 85 hours in elderly men.
This slow clearance is actually a partial buffer against withdrawal. Drugs with shorter half-lives (like paroxetine or venlafaxine) tend to produce more abrupt and intense discontinuation symptoms because blood levels drop sharply. Trintellix’s long half-life creates a more gradual decline, which is why withdrawal symptoms are delayed and, for many people, relatively mild compared to those other antidepressants.
What Withdrawal Feels Like
Trintellix withdrawal produces many of the same symptoms seen with other antidepressants that affect serotonin. Common complaints include dizziness, nausea, headache, irritability, and a general sense of feeling “off.” Some people experience what are sometimes called “brain zaps,” brief electric-shock sensations in the head. Sleep disturbances, vivid dreams, and anxiety can also surface during the withdrawal window.
These symptoms can overlap with a return of the depression or anxiety that Trintellix was treating in the first place, which makes the experience confusing. A useful distinction: withdrawal symptoms tend to appear within days of stopping and improve steadily over the following week or two. A true relapse of depression typically develops more gradually and doesn’t improve on its own with time.
Factors That Affect Severity
Not everyone who stops Trintellix will experience noticeable withdrawal. Several factors influence how rough the process is:
- Dose: Higher doses mean your brain has adapted to more of the drug’s activity, so the adjustment period can be more pronounced.
- Duration of use: The longer you’ve taken Trintellix, the more your brain has remodeled around its presence. Someone who took it for a few weeks will generally have an easier time stopping than someone who’s been on it for years.
- How you stop: Abrupt discontinuation produces more intense symptoms than a gradual taper. The chart review data showing 3-to-10-day symptom windows came from patients who stopped the medication, not from patients who tapered slowly.
- Individual biology: The drug’s half-life varies widely between people, from as short as 34 hours to over 113 hours. If you’re a fast metabolizer, your blood levels will drop more quickly, potentially making withdrawal more noticeable.
Why Tapering Matters
The 2024 Maudsley Deprescribing Guidelines, the first dedicated deprescribing reference from one of psychiatry’s most respected pharmacology sources, emphasize that safe antidepressant discontinuation should be guided by how much of the drug is actually occupying receptors in the brain, not just the milligram number on the pill. In practical terms, this means that cutting your dose in half doesn’t reduce the drug’s brain activity by half. The relationship is more complex, and the final reductions (from a low dose to zero) can actually be the hardest step.
For Trintellix specifically, a gradual dose reduction over several weeks gives your brain time to readjust. Dropping from 20 mg to 10 mg, then to 5 mg, with time at each step, is a common approach. Some prescribers use even smaller increments near the end. The goal is to make each step small enough that your brain barely notices the change, keeping withdrawal symptoms minimal or absent entirely.
What to Expect Week by Week
If you stop Trintellix abruptly or finish a taper, here’s a rough timeline based on the available clinical data and the drug’s pharmacokinetics:
Days 1 to 3: You’ll likely feel fine. The drug is still clearing from your system, and blood levels haven’t dropped enough to trigger symptoms. Trintellix takes about 12 to 14 days to reach steady state when you start it, so the reverse process of clearing out is similarly gradual.
Days 3 to 5: This is when withdrawal symptoms most commonly appear. Dizziness, nausea, irritability, and sleep changes are typical. Symptoms may feel mild at first and intensify over a day or two.
Days 5 to 10: For most people, this is the peak and resolution phase. Symptoms are at their strongest early in this window and gradually ease. The median resolution time is 7 days from onset, so most people feel noticeably better by day 10 after their last dose.
Days 10 to 14: The large majority of people have recovered by this point. If you’re still experiencing significant symptoms beyond two weeks, it’s worth distinguishing between lingering withdrawal and a possible return of the underlying condition.
Some people do report symptoms that persist longer than two weeks, particularly after years of use or higher doses. Extended withdrawal timelines are less well-documented in the medical literature for Trintellix specifically, but they are recognized as a possibility with antidepressants more broadly.